MO vs SRPT · P/E 14, rev $23.28B vs rev $1.90B
Altria Group (MO) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Altria Group (MO) is a tobacco company listed on US.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported MO revenue for 2025-12-31 was $23.28B. Net income was $6.95B. Revenue was down 3.1% from 2024-12-31 to 2025-12-31. MO currently screens at market cap $115.14B and trailing P/E 14.4.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
MO currently screens at market cap $115.14B and trailing P/E 14.4. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the MO and SRPT stock pages for the full models.
Not investment advice.